• By ICR Secretariat
  • Posted Tuesday, August 30, 2022

Axsome rebounds to win FDA approval of depression drug

https://www.biopharmadive.com/news/axsome-fda-approval-auverity-depression/630087/

The Food and Drug Administration on Friday approved a new depression drug from Axsome Therapeutics, one year after putting the treatment in regulatory limbo.